Qiagen N.V. (QGEN) Scheduled to Post Quarterly Earnings on Tuesday
Qiagen N.V. (NASDAQ:QGEN) is scheduled to issue its Q313 quarterly earnings data on Tuesday, October 29th. Analysts expect the company to announce earnings of $0.25 per share and revenue of $320.37 million for the quarter. Qiagen N.V. has set its Q3 guidance at $0.27 EPS and its FY13 guidance at $1.13 EPS.
Qiagen N.V. (NASDAQ:QGEN) last announced its earnings results on Tuesday, July 30th. The company reported $0.27 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.24 by $0.03. The company had revenue of $316.40 million for the quarter, compared to the consensus estimate of $311.75 million. During the same quarter last year, the company posted $0.25 earnings per share. Qiagen N.V.’s revenue was up 3.0% compared to the same quarter last year. On average, analysts expect Qiagen N.V. to post $1.03 EPS for the current fiscal year and $1.13 EPS for the next fiscal year.
Shares of Qiagen N.V. (NASDAQ:QGEN) traded up 0.02% on Monday, hitting $21.89. 66,010 shares of the company’s stock traded hands. Qiagen N.V. has a 52-week low of $16.98 and a 52-week high of $22.20. The stock’s 50-day moving average is $20.98 and its 200-day moving average is $20.21. The company has a market cap of $5.130 billion and a price-to-earnings ratio of 148.88.
QGEN has been the subject of a number of recent research reports. Analysts at TheStreet downgraded shares of Qiagen N.V. from a “buy” rating to a “hold” rating in a research note to investors on Monday, October 21st. Finally, analysts at BNP Paribas downgraded shares of Qiagen N.V. from a “neutral” rating to an “underperform” rating in a research note to investors on Friday, October 4th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $21.58.
QIAGEN N.V., (NASDAQ:QGEN) is a holding company, which provides sample and assay technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.